ArticleJournal of ovarian research2026
Ovarian leiomyoma revisited: a retrospective study of 18 cases with diagnostic and therapeutic implications.
Article in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study investigates the clinical characteristics, treatment strategies, and prognosis of ovarian leiomyoma, with the goal of enhancing diagnostic accuracy and therapeutic outcomes for this rare condition.
methodsWe retrospectively analyzed the clinical data of 18 cases of ovarian leiomyoma in our hospital from 2015 to 2024, including the clinical manifestations, imaging features, treatment and prognosis.
resultsThe mean age of the patients was 44.78 years. Among them, 88.89% were asymptomatic, with the disease frequently identified incidentally during physical examinations or surgical procedures. Imaging modalities such as ultrasound and MRI demonstrated limited preoperative diagnostic accuracy. Although ovarian tumors were detected in 63.6% of MRI scans, imaging cannot provide a definitive diagnosis of ovarian leiomyoma. Pathological examination remains the gold standard for diagnosing ovarian leiomyoma, with immunohistochemical staining typically positive for smooth muscle markers (ɑ-SMA, desmin). Management is primarily individualized surgical intervention, including either tumor resection with ovarian preservation or adnexectomy, with no recurrence observed in all cases post-surgery.
conclusionsThe diagnosis of ovarian leiomyoma remains challenging, as no reliable preoperative examination currently exists to definitively identify this condition. Accurate diagnosis typically requires correlation with postoperative pathological findings. Nevertheless, the prognosis for ovarian leiomyoma is generally favorable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.